Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1956 1
1957 1
1958 1
1959 1
1962 1
1965 1
1966 2
1969 1
1971 1
1973 2
1974 3
1975 1
1976 1
1977 2
1978 3
1979 7
1980 5
1981 14
1982 11
1983 6
1984 14
1985 14
1986 22
1987 22
1988 39
1989 24
1990 27
1991 36
1992 25
1993 59
1994 65
1995 66
1996 93
1997 87
1998 92
1999 102
2000 118
2001 143
2002 200
2003 237
2004 256
2005 370
2006 409
2007 492
2008 576
2009 714
2010 812
2011 968
2012 1196
2013 1453
2014 1686
2015 1936
2016 1904
2017 2219
2018 2479
2019 2808
2020 3183
2021 773
Text availability
Article attribute
Article type
Publication date

Search Results

23,143 results
Results by year
Filters applied: . Clear all
Page 1
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor.
Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, Fang Y, Deng J, Gao Y, Liang X, Lv J, Wang Z, Xie J, Xue Y, Zhang H, Ma J, Tang K, Fang Y, Cheng F, Zhang C, Dong B, Zhao Y, Yuan P, Gao Q, Zhang H, Xiao-Feng Qin F, Huang B. Liu Y, et al. Among authors: ma j. Nat Immunol. 2021 Mar;22(3):358-369. doi: 10.1038/s41590-020-00850-9. Epub 2021 Jan 11. Nat Immunol. 2021. PMID: 33432230
Regulation of Autophagy by Glycolysis in Cancer.
Chu Y, Chang Y, Lu W, Sheng X, Wang S, Xu H, Ma J. Chu Y, et al. Among authors: ma j. Cancer Manag Res. 2020 Dec 23;12:13259-13271. doi: 10.2147/CMAR.S279672. eCollection 2020. Cancer Manag Res. 2020. PMID: 33380833 Free PMC article. Review.
Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine.
Wang Y, Gao D, Liu Y, Guo X, Chen S, Zeng L, Ma J, Zhang X, Tian Z, Yang Z. Wang Y, et al. Among authors: ma j. Bioact Mater. 2020 Nov 19;6(6):1513-1527. doi: 10.1016/j.bioactmat.2020.11.016. eCollection 2021 Jun. Bioact Mater. 2020. PMID: 33294730 Free PMC article.
Optical Properties of Artemisinin and Its Derivatives.
Ma J, Qiao W, Mu X, Dong J, Quan J, Tian C. Ma J, et al. ACS Omega. 2020 Nov 23;5(48):30849-30857. doi: 10.1021/acsomega.0c03361. eCollection 2020 Dec 8. ACS Omega. 2020. PMID: 33324794 Free PMC article.
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
Chen YP, Lv JW, Mao YP, Li XM, Li JY, Wang YQ, Xu C, Li YQ, He QM, Yang XJ, Lei Y, Shen JY, Tang LL, Chen L, Zhou GQ, Li WF, Du XJ, Guo R, Liu X, Zhang Y, Zeng J, Yun JP, Sun Y, Liu N, Ma J. Chen YP, et al. Among authors: ma j. Mol Cancer. 2021 Jan 11;20(1):14. doi: 10.1186/s12943-020-01292-5. Mol Cancer. 2021. PMID: 33430876 Free PMC article.
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.
Chen YP, Ismaila N, Chua MLK, Colevas AD, Haddad R, Huang SH, Wee JTS, Whitley AC, Yi JL, Yom SS, Chan ATC, Hu CS, Lang JY, Le QT, Lee AWM, Lee N, Lin JC, Ma B, Morgan TJ, Shah J, Sun Y, Ma J. Chen YP, et al. Among authors: ma j. J Clin Oncol. 2021 Mar 1;39(7):840-859. doi: 10.1200/JCO.20.03237. Epub 2021 Jan 6. J Clin Oncol. 2021. PMID: 33405943
23,143 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page